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A B S T R A C T
In recent years, a great deal of interest has been focused on the development of novel atomic force mi-
croscopy (AFM)-based methods. From ﬁrst being an unstable method, AFM has emerged as the perfect
tool for the study of phenomena at the nanoscale, which includes quantitative single molecule studies.
Numerous novel AFMmethods play a crucial role in the invention of novel drugs, their delivery systems,
based on either polymers or inorganic/metallic matrices, and in the examination of disease-related tissue
changes. Such contemporary progressive studies are a perfect example of interdisciplinary research, which
results in exemplary ﬁndings and discoveries. This review focuses especially on the literature published
in the last decade; however the most important earlier discoveries are also included.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
1.1. Surface properties of solid pharmaceutical forms
The surface properties of solid pharmaceutical dosage forms,
which have a major inﬂuence on the ﬁnal pharmaceutical product
and therefore its use, are determined during preformulation and for-
mulation studies. In the course of evaluating pharmaceutical
formulations, the respective components can exhibit signiﬁcantly
different properties. Furthermore, the measured properties can be
locally speciﬁc and therefore do not truly represent the bulk prop-
erties of the whole system. Several characterisation methods also
rely on averaging, making measured properties not appropriate for
describing the separate components. Such component-speciﬁc in-
formation is crucial for predicting ﬁnal product performance,
enabling a thorough understanding of the overall bulk properties,
and can only be obtained when measurements are performed sep-
arately at several representative points on the surface and are
analysed as separate entities. Finally, the statistical validity of such
measurements is of utter importance, permitting a thorough un-
derstanding of the examined materials [1,2].
While the European Pharmacopeia prescribes several tests that
are important for pharmaceutical formulations safety and quality,
several other important physicochemical properties arising due to
interactions between the components comprised in the pharmaceu-
tical formulation contribute to the ﬁnal product properties and
therefore require attention [3,4]. The surface roughness, grain size,
polymorphism, and surface energy of standalone components and
interaction among them are just some of the surface characteristics
thatmaysigniﬁcantly inﬂuence thebioavailabilityof thebuilt-in active
ingredient and consequently its eﬃciency [5]. Although variouswell-
known methods are being used for the local characterisation of
pharmaceutical formulations (electronmicroscopy, contact anglemea-
surement, thermal analysis, x-raypowderdiffraction, andothers), none
of them is able to evaluate the regionally speciﬁc properties in a com-
plete and reliableway.At themoment, atomic forcemicroscopy (AFM)
is themostwell-knownalternative for thoroughqualitative andquan-
titative evaluation of pharmaceutical formulations with regard to
surface properties that can affect the ﬁnal formulation characteris-
tics. In addition,AFMis theonlyavailable techniquewith thecapability
to measure interactions in the pN range, which makes it one of the
most important tools for in biomedicine.
1.2. About the technique
The AFM technique was introduced in 1986 by Binning, Quate,
and Gerber with the intention of overcoming the drawbacks of its
predecessor, the scanning tunnelling microscope (STM) [6,7]. The
most prominent upgrades are the capability of AFM to also measure
non-conductive samples and to measure the surface topography of
samples at sub–nanometer resolution [8].
A schematic representation of the basic AFM set-up is shown in
Fig. 1a. When using AFM a tip attached to a ﬂexible cantilever moves
across the sample surface, measuring the surface morphology on
the atomic scale. The force between the tip and the sample is mea-
sured during scanning, bymonitoring the deﬂection of the cantilever
[11].
1.2.1. The force between the sample and the tip
In order to understand the mechanisms behind the interacting
components in a pharmaceutical formulation all the contributing
forces must be taken into account. This is especially important when
a quantitative analysis of the interaction is required, as in the case
of interactions between biological macromolecules [12]. The forces
between the tip and the substrate have short- and long-range con-
tributions. When measurements are performed, it is crucial to
separate the contributions of various forces and to eliminate the un-
desired ones. This ensures the measurement of only the desired
sample properties and makes further quantitative analysis possi-
ble [13,14]. At room conditions, water moisture can condense on
the tip, which is a source of capillary force. As the capillary forces
are relatively strong and can cover the contributions of other forces,
they have to be avoided if possible. This is possible by measuring
in special water-free conditions, such as in a N2 or Ar atmosphere.
To represent forces on the atomic level, different potentials cor-
responding to changes of potential energy at various particle
positions are used. Known empirical models used to illustrate chem-
ical bonds include the Lennard-Jones andMorse potentials [9]. These
models quite satisfactorily ﬁt the force regime curve shown in Fig. 1b,
which represents the course of the tip-sample interaction. Never-
theless, these models are not always applicable due to experimental
limitations such as sample contamination and to many contribu-
tions to the measured interaction [9].
1.2.2. Special AFM modes
Many different variations of the basic AFM set-up have been in-
troduced over the years of its use. Although most of them are
applicable to all types of samples, not all yield the same amount
and quality of results for all experimental set-ups. Proper use of these
versatile measurement variations enables one to study and under-
stand processes even at the molecular level [15,16].
1.2.2.1. Contact mode. Contact modewas the ﬁrst known AFMmode.
Here, the tip moves across the surface and deﬂects according to its
Fig. 1. Atomic force microscopy. a) Schematic presentation of AFM; b) Force regimes governing AFM measurement (this image was drawn considering the explanation in
[9] and was partially reproduced from [10]).
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proﬁle (Fig. 2a). Two types of contact mode measurements are
known, the constant force mode and the constant height mode. In
the constant force mode, a feedback loop is used tomove the sample
or the tip up and down and keep its deﬂection constant. The value
of z-movement (z is height) is equal to the height changes in the
surface of the sample. The result of such measurement is informa-
tion about the surface topography. Since the tip is in constant contact
with the surface, signiﬁcant frictional forces appear, which can
destroy or sweep soft samples, such as polymers or biological mac-
romolecules on the surface [18]. Such an approach was mostly used
for examining surfaces of solid pharmaceutical formulations [19,20].
When small forces are used, this mode can also be used for surface
topography imaging of ﬁxed cells [21,22].
The other type of contact mode AFM measurement is based on
a constant height, but the forces change. In this case, the cantile-
ver deﬂection is measured directly and the deﬂection force on the
tip is used to calculate the distance from the surface. Since no feed-
back loop is required for this type of measurement, it is appropriate
for quick scans of samples with small height differences (if height
differences are large, the tip will very likely crash onto the surface,
resulting in either it being destroyed or in it damaging the sample
surface). With this type of measurement, atomic resolution is
achieved at low temperatures and in a high vacuum. Such mea-
surements are often used for quick examination of fast changes in
biological structures [15,23,24].
1.2.2.2. Non-contact mode. In non-contactmode, the sample’s surface
is investigated using big spring constant cantilevers. The tip hovers
very close to the surface (approximately 5–10 nm distant). It never
comes into contact with it, hence the name non-contact mode
(Fig. 2b). A major advantage of this mode is the negligible fric-
tional forces, making it capable of measuring biological samples
without altering their surface, as well as its speed. The major draw-
backs of this mode are the low lateral- and z-resolution when
compared to contact mode. Recently, it was used for a thorough ex-
amination of speciﬁc regions of cell surfaces [25–27] and for the
characterisation of single polymer chains [28,29].
1.2.2.3. Lateral force microscopy. In lateral force microscopy (LFM),
an AFM is used tomeasure the frictional forces on the surface. Instead
of the z-deﬂection, the lateral deﬂection is measured. This mea-
surement requires more robust tips and cantilevers that are not
destroyed in the event of high frictional forces, which are common
in suchmeasurements. LFM enables the determination of the regions
on the substrate surface with lower or greater friction. Data ob-
tained in the measurement of lateral forces is composed of actual
frictional forces and the inﬂuence of the height change of the sample
(Fig. 2c in 2d). In order to acquire appropriate friction informa-
tion, the contributions of lateral forces and sample topography are
measured and the latter is computationally subtracted from the total
data. The resulting image shows the contribution of the surface fric-
tion only. Such an approach is especially useful for samples exhibiting
multicomponent (not layer-by-layer) surface coatings, such as in
eroding drug delivery systems, as it can reveal the regions of dif-
ferent materials in the coating [30]. Appropriate release studies
combined with LFM information can be a basis for development of
controlled release dosage forms [31,32].
1.2.2.4. Force modulation. In force modulation, repulsive forces
between the sample and the tip are used to investigate the sample
properties. In this mode, the AFM tip has to be coated with mate-
rials that exhibit repulsive forces with the sample surface (for this
purpose, the sample is also sputtered or coated in certain cases).
The tip is then oscillated at a high frequency, and moved to a dis-
tance at which the repulsive forces act. Such experimental set-up
allows high resolution, non-destructive topography measure-
ments. If some additional approximations, e.g. in relation to the
homogeneity of the materials and an inert tip surface are consid-
ered, the force versus distance curves can be measured. Sample
elasticity can be calculated by using different theoretical models [9].
Such measurements are especially interesting for multicompo-
nent coatings, because local variations can be calculated as well
[33–35]. A schematic representation of the force modulation mode
is shown in Fig. 3a.
1.2.2.5. Phase imaging. In phase mode imaging, the phase shift of
the cantilever oscillation is compared to the driving signal (Fig. 3b).
This difference is shown in a separate image window in most con-
ventional AFMs. Different samples exhibit various interactions with
the AFM tip and hence the corresponding phase shift is altered. The
sample properties that are inﬂuenced by the interactions with the
AFM tip include friction, adhesion and high elasticity. Use of this
Fig. 2. Schematic representation of different AFMmodes. a) the contact mode, b) the non-contact mode, c) and d) lateral force microscopy (LFM), where the frictional forces
appear on the cantilever due to different materials and different surface shapes, respectively. Images a), b), c), and d) were drawn after the explanation in [17] and partially
reproduced with permission from [10].
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mode is sometimes the only way to show differences between local
regions on the sample [37,38]. In pharmaceutical sciences, this mode
is very useful for the examination of the consistency of the outer
coatings of solid pharmaceutical formulations and for exposing cracks
and other degradation features [39–41].
1.2.2.6. Amplitude modulation mode or dynamic force
mode. Developed based on the non-contact mode, this mode is often
also called the intermittent-contact or tapping mode. It eliminates
the major weaknesses of the non-contact mode, such as the low
lateral resolution and z-resolution. Instead of hovering above the
sample, the cantilever vibrates above the surface andmoves through
the force gradient above the surface, during which it might mo-
mentarily touch the surface [42]. Due to interactions of the AFM tip
with the sample surface, the amplitude of vibrations decreases and
a phase shift occurs (Fig. 4a). One of these parameters may be chosen
(amplitude or phase shift) and kept constant through the feed-
back loop by moving either the sample or the tip in the z-direction.
This provides information about the surface topography, similar to
the contact mode. In order to measure in the amplitude modula-
tion mode, much stiffer cantilevers are needed, which exhibit the
smallest possible damping factors (this factor is commonly re-
ferred to as the Q-factor) [43,44].
Amplitude modulation mode is the most often used AFMmode
in biomedical applications due to its high resolution, the nearly non-
destructive nature of the imaging, and its applicability in air and
also in liquid conditions [45,46]. Many researchers have used this
technique to clarify or conﬁrm their results and to show high-
resolution images of their samples, which in bio-related sciences
is often the only way to prove their claims [47,48].
For the last couple of years, many researchers have been trying
to explore the material characteristics even further by using the am-
plitude modulation mode while introducing multi-frequency
measurements [49]. Since improving the spatial resolution, data ac-
quisition times, and imaging of material properties are perennial
goals in amplitude modulation AFM, multi-frequency measure-
ments seem to be very promising for future research in biomedicine
[50,51]. At present, the best results were gathered by exciting and
detecting several frequencies of the tip oscillation. These frequen-
cies are usually associated with either the higher harmonics of the
oscillation or the Eigen modes of the cantilever [52,53]. The most
recent studies using the mentioned approach include, e.g., the
mapping of the nanomechanical properties of living cells [54–56].
1.2.2.7. Force spectroscopy. Upon contact with the sample surface,
the tip experiences a force, which is monitored as a change in the
deﬂection of the cantilever [6]. This force is a function of the tip-
sample separation and the material properties of the tip and the
sample and can be used to investigate the characteristics of the
sample, the tip, or the medium in between [57]. The AFM force mea-
surement procedure for gathering force curves is schematically
depicted in Fig. 4b.
In addition to determining interaction forces between the tip and
different (mostly model) surfaces, AFM can also produce two-
dimensional chemical aﬃnity maps by modifying the cantilever tip
with speciﬁc molecules [58]. Such tip modiﬁcations enable the char-
acterisation of differently responding regions on thematerial surface,
resulting in a better understanding and, consequently, application
of the examined materials [59]. In this way even quantitative data
Fig. 3. Force modulation mode. a) the working principle of the force modulation mode (parts of this image were reproduced with the permission of C. Roduit [36]) and b)
a schematic representation of the phase imaging mode (this image was prepared in light of the explanation in [17]).
Fig. 4. Amplitude modulation mode. a) a schematic representation of the amplitude modulation mode and b) a typical force curve. When approaching the surface, the can-
tilever is in an equilibrium position (1) and the curve is ﬂat. As the tip approaches the surface (2), the cantilever is pushed up to the surface – being deﬂected upwards,
which is seen as a sharp increase in the measured force (3). Once the tip starts retracting, the deﬂection starts to decrease and passes its equilibrium position at (4). Moving
away from the surface, the tip snaps in due to interaction with the surface and the cantilever is deﬂected downwards (5). Once the tip-sample interactions are terminated
due to increased distance, the tip snaps out and returns to its equilibrium position (6). Parts of the images were reproduced from [10].
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can be gathered, which can be used to identify the forces involved
in the speciﬁc biological systems [60–62].
Mapping the functional groups and examining their interac-
tions with different materials is of signiﬁcant importance for
problems ranging from lubrication and adhesion to the recogni-
tion of biological systems and other biomedical applications
[15,63–65]. Changing the environmental conditions during themea-
surement has also been used extensively to monitor changes in the
interactions among different functional groups and surfaces to sim-
ulate the behaviour of the materials upon exposure to a real
environment [4,59,66].
Nowadays, the ultimate use of AFM is for single-molecule rec-
ognition, which can be achieved by applying force spectroscopy.
Although the study of single molecules by AFM started several years
ago [67], breakthrough discoveries have only been made recently
[68–72].
The recent advancement of AFM force spectroscopy has allowed
the introduction of single molecule force measurements, e.g. dif-
ferent biological macromolecules like chitosan, RNA, andmonoclonal
antibodies [60,73–76].
2. Examples of AFM use in drug discovery and development
Several reports point out the applicability of AFM and its dif-
ferent modes in different areas of pharmaceutical research
biomedicine and biophysics [12,39,77]. To demonstrate actual proof
of the unprecedented features of AFM, which are right at the limit
of experimental capabilities, we have structured the novel re-
search reports into several sub-sections with regard to the emphasis
of the research possibilities.
2.1. Drug discovery
In recent years, numerous research articles regarding drug dis-
covery through use of AFM have appeared [12,78,79]. The unique
ability of AFM to provide structural information about molecules
at the single molecule level enables thorough study of their
behaviour at simulated physiological conditions [79].
2.1.1. The search for novel drug targets
Edwardson and Henderson reviewed the possibilities to use AFM
for the study of novel drug targets, such as proteins (Fig. 5 shows
the possible effect of novel drug candidates on a chosen mem-
brane protein) and DNA and the folding of modular proteins using
single molecule force spectroscopy [79,80].
AFM-based drug discovery is possible either by testing the in-
teractions of drugs with model receptors, or by testing the contact
of the novel drug candidate with target cell membranes, which often
pose an impenetrable barrier for them [81,82]. Such drugs often
require the use of costly delivery systems. Alternatively, novel can-
didates can be studied on carefully designed model systems, which
can indicate the actual potential of the respective drugs prior to costly
pre-formulation [83]. Peetla et al. discussed the importance of the
use of differentmodel membranes and the biophysical study of drug-
membrane interactions in drug discovery. They mentioned AFM as
one of the possible benchmark methods for successful “ﬁshing” for
appropriate drug candidates, which need to pass such lipid mem-
branes. Additionally, they pointed out the signiﬁcance of these
interactions and the interactions of a model membrane with
nanocarriers upon the incorporation of potent drugs [84]. In Fig. 6,
clear morphological changes on model membranes can be ob-
served, following interaction with nanoparticles.
There is no evolution and progress without proper develop-
ment and monitoring of the latest technological advancements in
any scientiﬁc ﬁeld. The latter is especially true in drug discovery,
where several new nano- and micro- technological advancements
are pushing the boundaries of the applicability of new drugs
[12,78,85]. The progress in AFM development and the addition of
several new modes have already proven the usability of AFM for
the identiﬁcation and examination of drug candidates and the de-
velopment of new delivery technologies [12]. Both are often required
to transform biological potential into medical reality, thus contrib-
uting to the acceleration of the drug discovery and formulation
development process [12].
The classic therapeutic design involves combinatorial chemis-
try and system biology-based molecular synthesis, aided by bulk
pharmacological assays. To increase the eﬃciency of therapeutic
discovery and delivery, one should understand the therapeutic–
effector interactions and their cell and tissue responses at the
molecular level [12]. Lal et al. reviewed recent advances in the use
of multidimensional scanning probe techniques, especially AFM
for drug discovery [86]. Multidimensional AFM introduces simul-
taneous measurement at different tip oscillations (often referred
to as higher harmonics). Each of these higher harmonics can yield
different information with regard to the sample characteristics by
which the ﬁnal measurement output becomes even more thor-
ough and conclusive [86–88]. This was evident in the research paper
of La et al., where multidimensional AFM measurement for deﬁn-
ing targets was used for designing therapeutics and monitoring
their eﬃcacy [12].
2.1.2. Identiﬁcation of species
Many diseases evolve as a consequence of unwanted morpho-
logical changes in healthy tissue. The identiﬁcation of species in the
body causing disease-related symptoms and the response of the
human body to these changes are crucial parameters for a success-
ful struggle against disease or for the development of effective cures.
AFM has proven to be one of our best shots in the identiﬁcation of
disease-related structural changes [78,89].
Fig. 5. AFM in search for novel drug targets. AFM imaging of human aquaporin-1
(AQP1). (a) deglycosylated hAQP1 2D crystals before carboxypeptidase Y treat-
ment. (b) after carboxypeptidase Y treatment. (c) The symmetrised correlation average
shows a windmill-like structure of 1.5 nm height on one side and a pronounced de-
pression with a windmill-shaped peripheral (1) and central protrusions (2) on the
other side. (d) In the symmetrised correlation average of the deglycosylated and de-
carboxylated hAQP1, the high windmill-like structure was unchanged. On the lower
side, the central protrusion (2) had disappeared, while the peripheral one (1) ap-
peared to be unaffected by the digestion. (e) Differences are evident in this difference
map between the undigested and digested hAQP1 topographs [see the contours in
(d)]. (Figure reproduced from [79]).
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Legleiter et al. used ex situ AFM to gain insight into the physi-
cochemical processes involving antibodymorphology, with important
implications for the key factors involved in neurodegenerative
changes, as the underlying cause of Alzheimer’s disease [89]. In their
study, AFMwas used to study antibody aggregation, considering the
role of the antibody epitope speciﬁcity of antibodies as potential
inhibitors of ﬁbril formation. Ono et al. reviewed recent develop-
ments in the synthesis of molecules that are used to inhibit the
formation of α–Synuclein (αS) ﬁbrils as well as the oligomerisation
of αS [90]. These molecules were conﬁrmed as small units of protein
aggregates in the brain that constitute histopathological features
of Parkinson’s disease [91]. Although themechanisms bywhich these
new compounds inhibit the formation of αS ﬁbrils and destabilise
already formed ﬁbrils are still unclear, they could represent the future
of novel therapeutics for Parkinson’s disease, as well as for other
neurodegenerative diseases exhibiting similar pathophysiological
changes in the brain [89,92,93].
2.2. Pharmaceutical technology
The possibility of following different physiological and pharma-
cological responses in a simulated environment in real time, while
changing either the parameters or composition of the liquidmedium
used, is one of the most important features AFM can deliver [94,95].
Combining the above-mentioned with quantitative measurement
of forces between interacting species, resulting in knowledge about
sample hardness, elasticity, miscibility between components, and
the degree of aggregation, makes AFM a very valuable addition to
the usual set of techniques used in preformulation studies [4,96].
2.2.1. Drug delivery
Due to its non-destructive nature, AFM can be used for re-
search of soft systems under various controlled environmental
conditions. Such studies can serve as a unique foundation for the
in vitro development of novel drug delivery systems [39,77,97,98].
Tumer et al. report on the main use of AFM and its success in pro-
gressive drug delivery development. They focus especially on the
possible aid of AFM in preformulation and formulation studies [97].
One of the still unanswered questions regarding the delivery of
drugs to and through the skin concerns the particle size limit at
which the ability to penetrate the stratum cornea ceases [99]. Prow
et al. reviewed recent advances in the use of different nano- and
micro- particles for skin drug delivery and also presented some of
their unpublished data from clinical studies. AFMwas put made the
focus of this review because of its ability to evaluate molecular in-
teractions between the particles used and the biological systems
that are the basis of understanding the eﬃciency and possible side
effects of skin delivery formulation [99]. The understanding of in-
teractions between nanoparticles and common structures of skin,
e.g. furrows, hair follicles, eccrine ducts, etc., is critical to the im-
provement of percutaneous drug delivery and in the design of skin
drug delivery systems, like lipid nanoparticles, as well as dendrimers
that exhibit the capacity for customised pharmacokinetics [99,100].
2.2.2. Determination of the structural properties of pharmaceutical
formulations
Excipient behaviour after exposure to certain environmental con-
ditions during drug production or use is one of the most important
characteristics for the pharmaceutical technology and industry
[101–103]. The production of novel formulations depends on ob-
taining laboratory-scale analyses, which can have a costly outcome,
if not conducted properly. Wu et al. used AFM to help identify char-
acteristics of two transition points of trechalose, a commonly used
cryo-protectant in lyophilised dosage forms for parenteral appli-
cation [104]. Their measurements were able to clearly differentiate
between the samples’ glass transition and the loss of crystallinity.
When combined with thermal analysis, such studies could serve as
a perfect platform for testing excipient suitability in the mixture
for the ﬁnal formulation [104]. Another related research area where
AFM already proved able to explain several ﬁnal formulation in-
compatibilities is the study of material miscibility [103]. Lauer et al.
studied the possibility of developing a method for predicting the
drug/polymer miscibility and stability of solid dispersions using a
melt-based mixing method. Their method was developed using a
combination of Raman spectroscopy and AFM to differentiate
between homogenously and heterogeneously mixed drug/polymer
combinations [103]. Knowledge of miscibility is the basis for the
preparation of stable formulations and the avoidance of subse-
quent possible incompatibilities of the ﬁnal products. Their
experimental set-up serves as a great starting point for further AFM–
based miscibility evaluation.
Metastable pharmaceutical formulations are often used in phar-
maceutical technology due to their very useful characteristics. Solid
dispersions are one of the more commonly used formulations to
Fig. 6. AFM in search for novel drug targets – different modes. Surface morpholo-
gy of the endothelial cell model membrane (EMM) following interaction with NPs.
Langmuir–Schaeffer ﬁlms were transferred onto a silicon substrate following inter-
action with NPs for 20 min and the imaging was carried out using AFM in tapping
mode in air. (a) EMM alone, (b) EMM following interaction with RNPs, and (c) EMM
following interaction with TAT200-RNPs. The EMMwas transferred at the SP 29mN/m
for (a), whereas (b) and (c) were transferred at the SP 31 and 36 mN/m, respective-
ly. The corresponding zoom images for (a), (b), (c) are (d), (e), (f). The height scales
for the images were: a = 3 nm; b, c = 150 nm. (Figure reprinted with permission from
[84]. Copyright (2015) American Chemical Society.).
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improve the solubility of drugs [105]. The crucial characteristics con-
nected with the ﬁnal solid dispersion behaviour aremostly the result
of the drug crystallite size and the homogeneity of its dispersion
through the material. AFM proved very successful in both the
imaging of different regions of the solid dispersion and in the de-
termination of crystallite sizes with a high degree of eﬃciency. The
correlation of the latter with dissolution testing was helpful in pre-
dicting the dissolution behaviour of solid dispersions made of drugs
and different polyethylene glycols (PEGs) [105]. Pegylated sur-
faces have a long history of use in biomedicine. Although they are
part of many drug delivery systems and their general characteris-
tics are already known, additional knowledge of the correlation
between their structure and their behaviour in different circum-
stances is still needed to extend their potential even further
[106,107]. One of the efforts to expand such knowledge was per-
formed by Sant et al. [108]. They conﬁrmed the importance of
polymer architecture in determining the surface properties of the
ﬁnal material or product (Fig. 7) and hence the protein binding and
cellular interactions of nanoparticles. AFM was also used to show
the reducedmacrophage uptake of grafted copolymer nanoparticles
(NPs) as compared to multiblock copolymer grafted NPs. Al-
though the uptakemechanisms involved could not be fully explained
by AFM only, this is a nice indication of how AFM-based studies can
be used to gain further insight into material properties [108].
Amorphous materials, either drugs or excipients, are an inter-
esting form of metastable formulation in different biomedical
applications. Mao et al. developed a general method to induce a
metastable or amorphous form of an active pharmaceutical ingre-
dient (API) by chemical conﬁnement under high undercooling
conditions [109]. In their research, AFM was used to study the pro-
duced ﬁlm structure and morphology related to the changed form
and improved characteristics. The results can be used as the basis
for explaining the aggregation and deposition of Aspirin® on amodel
bilayer surface, serving for further development of carrier systems
involving the drug and phospholipid bilayers [109]. Using AFM, the
authors proved that the advantage of such structures lies in the in-
creased solubility and bioavailability achieved by preparation of a
metastable form of API.
Currently, a great deal of interest has been focused on the ap-
plicability of several AFM modes in studying specially designed
pharmaceutical formulations to address and explore its suitability
for improving formulation design [110–112]. Veerapandian and Yun
reviewed AFM applications in pharmaceutical and biopharmaceutical
areas with a special emphasis on the investigation of the crystal
growth, polymorphism, particles, granules, and coating morphol-
ogy of the solid dosage form for the optimisation of solid dosage
form behaviours [4]. They additionally highlighted in situ
biopharmaceutical investigation of cell-macromolecular surface,
drug–drug, drug-cell, drug-DNA, DNA-protein, drug-enzyme, and
antigen-antibody interactions, as well as the disease mechanisms
for a better understanding of the physiological mechanisms asso-
ciated with disease in order to rationalise drug design and
development [4].
2.2.3. Biophysical examination
This special area of biomedicine addresses the physical aspects
of the underlying mechanisms among interacting species occur-
ring between biological species and medicines.
Liao et al. have used AFM nanoindentation to determine hard-
ness, stiffness, and creep in a single measurement for four materials
commonly found in medicine in tablet form [20]. The proposed
method worked equally well with both soft and hard materials. A
similar approach was used by Masterson and Cao, who imple-
mented AFM nanoindentation to evaluate the hardness of the
individual particles of various pharmaceutical solids including
sucrose, lactose, and ascorbic acid, and the inﬂuence of ibuprofen
on the measured parameters [96]. Their research was focused es-
pecially on the effects of data variation regarding indentation size
and peak load on hardness. The results showed acceptable repro-
ducibility and indicated that data variation may appear primarily
from the inhomogeneous nature of the samples, pointing out the
importance of sample preparation [96,113,114].
Zhang et al. determined the contact adhesion forces between an
AFM tip and lactose in an environment with low humidity. This tech-
nique can identify the submicron heterogeneity of organic solids
in terms of their molecular energy states (such as ordered and dis-
ordered lactose) [115]. Another interesting study regarding the
excipient lactose was performed by Bunker et al., who electrically
charged single particles of lactose by contact mode AFM scanning
and veriﬁed the increased electrical charge by measuring the dif-
ference in the long-range electrostatic forces with force spectroscopy
measurements [116]. Such an approach is especially interesting in
the case of the preparation of pharmaceutical formulations requir-
ing a mixture of different components to interact with each other,
such as in the case of tablets whose ﬁnal hardness can be signiﬁ-
cantly affected by shattered interaction forces between different
constituents. With regard to formulation testing, AFM can addi-
tionally be used as a measure for the determination of segregation
processes and their extent in different mixtures and conditions
[117,118]. Duong et al. performed AFM force vs. distance measure-
ments for samples with various amounts of water in the mixture.
They tried to determine the correlation between the segregation
process and moisture-induced cohesion, which often causes inho-
mogeneities in pharmaceutical formulations [117].
The adhesive and cohesive forces and their intertwining in a
mixture of a drug and excipients often result in industrial-scale prob-
lems in themanufacturing process. The AFM colloid probe technique
has emerged as a tool for obtaining a quantitative assessment of
the cohesive and adhesive forces and was tested to evaluate the co-
hesive and adhesive balance within dry powder inhaler formulations
containing an active ingredient (budesonide, salbutamol sul-
phate) and alpha-lactose monohydrate [119]. Begat et al. developed
special cohesive-adhesive balance (CAB) graphs to allow a direct
comparison of the interaction forces occurring in model carrier-
based formulations. Their novel approach could be very interesting
for the evaluation of cohesive-adhesive balances in dry powder for-
mulations and for a further understanding of powder behaviour for
variousmixtures, which is crucial for structure activity relation (SAR)
evaluation on a laboratory or industrial scale [119].
2.2.4. Transport phenomena
The transport phenomena play an important role in the devel-
opment of drug delivery systems, where the behaviour of the
Fig. 7. Amplitude modulation “tapping” mode AFM images of NPs. The upper panels
show topography and the lower panels show the corresponding phase images; all
images were acquired in air. Scan size: 250 × 250 (nm × nm); PLA (a), PEG1%-g-PLA
(b), PEG5%-g-PLA (c), PLA-PEG-PLA)n (d). (Figure reproduced from [108] with per-
mission.).
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developedmaterials upon contact with the body ﬂuids plays a major
role in their eﬃciency determination. AFM provides the tools for
studying such phenomena with a molecular resolution, while ad-
ditionally allowing measurements in specially designed liquid
environments, simulating physiological ones [77,120]. Burgos et al.
studied how adhesion forces were affecting the surface energy gra-
dients, resulting in directed single molecule diffusion [121]. Such
information and its validity could be a novel basis for the devel-
opment of controlled delivery systems, where the complex and
diﬃcult to explain dissolution mechanisms are necessary for suc-
cessful therapy [122]. An attempt to use the study of transport
phenomena to improve drug delivery systems was made by Peetla
et al., who studied the role of lipids in drug transport. Lipid-
related drug transport is especially critical in cancer chemotherapy
to overcome drug resistance [123]. Biophysical interaction studies
on cell membrane lipids might therefore be helpful in improving
drug transport and eﬃcacy through drug discovery and/or drug de-
livery approaches by overcoming the lipid barrier in resistant cells.
AFM contributed greatly to this study as it was the main method
of surface characterisation before and after the interactions oc-
curred [123].
One of the most promising uses of force spectroscopy in phar-
maceutical physics is its use for interaction mapping among
biological species (membranes, proteins, DNA, etc.) with novel or
existing pharmaceutical formulations. Jadhav et al. pointed out the
role of cell adhesion in diverse biological processes that occur in
the dynamic setting of the vasculature, including inﬂammation and
cancer metastasis [124]. Consequently, elucidating the molecular
and biophysical nature of cell adhesion requires a multidisci-
plinary approach combining the synthesis and preparation of in vitro
models, with fundamental knowledge of the hydrodynamic ﬂow,
molecular kinetics, cell mechanics, and biochemistry [124,125]. Ex-
perimental work at the nanoscale to determine the lifetime,
interaction distance, and the strain responses of adhesion receptor-
ligand bonds has been accelerated by the introduction of AFM,
combined with the use of biomolecular force probes [126]. Al-
though such research efforts started several years ago, our current
knowledge in this area is still far from complete [124,127]. The pro-
gress of such studies is key to the development of mathematical
models of cell adhesion that incorporate the appropriate biologi-
cal, kinetic, andmechanical parameters leading to reliable qualitative
or even quantitative predictions, which could increase the success
rate of diagnostics and ﬁghting diseases [128–130]. Jadhav et al.
explain multiscale mathematical models which can be employed
to predict optimal drug carrier-cell binding through isolated pa-
rameter studies and engineering optimisation schemes, which will
be essential for developing effective drug carriers for the delivery
of therapeutic agents to the aﬄicted sites of the host [124,131,132].
2.3. Bionanotechnology and nanobiotechnology
One of the main reasons for the staggering progress in
bionanotechnology and nanobiotechnology in recent years is the in-
troduction of several experimental methods, corroborated by
theoretical considerations, into the study of biological phenome-
na [133–136].
Jain explains how several technologies, including the prepara-
tion of nanoparticles and nanodevices in the form of nanobiosensors
and nanobiochips, may be used to improve drug discovery and de-
velopment [135]. Novel and upgraded nanoscale assays can
contribute not only to more eﬃcient drug discovery, but can also
contribute signiﬁcantly to cost-saving in screening campaigns.
Looking at the number of research reports in the ﬁeld of health-
related nanotechnology, it is clear that the future prospects for the
application of nanotechnology in healthcare and for the develop-
ment of personalised medicine appear to be promising [135].
With a special interest on new bioassays, based on technolog-
ical advancements in recent years, Hong and Root reviewed several
new research reports regarding the use of single–molecule assays
and evaluated their suitability for drug development. One of the key
advantages they pointed out was the small amount of sample needed
to perform such studies [137]. Biological samples are often expen-
sive due to their costly production and cleaning procedures. Indeed,
only small amounts of the examined material are needed for the
preparation of AFM samples. In order to avoid unwanted contami-
nations of any kind and resulting unusable measurements, strict
routines need to be followed [113].
Kada et al. prepared an exemplary review of recent AFM devel-
opment in various biological sciences, where knowledge of the
structure and characteristics at the molecular level can be of utter
importance [136]. Some examples of recent advances regarding the
visualisation of biological macromolecules and the measurements
of molecular recognition forces are shown in Fig. 8. Probably one
of the most impressive additions to the study of biological samples
is the combination of AFMwith ﬂuorescence microscopy [138,139].
This might be the future of biological studies at the molecular level.
Bionanotechnology combines nanotechnological advance-
ments with the knowledge of the biological world, where biological
macromolecules serve different natural and artiﬁcial purposes [140].
Regarding this, Campolongo et al. reviewed the potential of differ-
ent DNA–based structures and templates that can be used in
Fig. 8. High-resolution topographical imaging of biomolecular assemblies. (a) 3 kbp
(base pairs) pDNA on a mica surface imaged in Ni2+-containing buffer solution. Scale
bar 150 nm. (b) Left: crystalline arrangement of human rhinovirus on a lipid bilayer
containing receptors. Inset: Fourier spectrum and average lattice. Right: dense packing
of virus particles with regular patterns of small protrusions ≈0.5 nm high and ≈3 nm
in diameter. (c) Topographical image of a purple membrane to which a single an-
tibody is bound (left) and a three-dimensional representation (right). (Figure
reproduced from [136] with permission.).
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nanomedicine [141]. The second rise to fame for DNA (the ﬁrst one
was its discovery, isolation, and cracking) was certainly the realisation
that its structural characteristics made it a perfect template or even
a backbone for the design of several novel and extraordinary
nanostructures [142,143]. These new DNA-based structures have
opened a whole new avenue for research towards different poly-
meric topologies. Such topologies, in turn, possess unique
characteristics that translate into speciﬁc therapeutic and diagnos-
tic strategies. Study of such phenomena at the nanoscale is only
possible by introducing AFM–based techniques into research
[141,144,145].
2.3.1. Study of disease-related changes
Diseases lead to various pathophysiological changes in the body,
whether these are structural or compositional. Either way, they can
ultimately be used as a marker for the early detection of the un-
derlying disease. Therefore researchers often focus their studies on
the identiﬁcation of such markers. Stolz et al. used the indenta-
tion type of force microscopy to monitor age-related morphological
and biomechanical changes in the hips of normal and osteoar-
thritic mice [146]. Changes in the micro- and nano-stiffness were
observed well before the morphological changes could be de-
tected with the currently used diagnostic methods. Such research
is very encouraging for further studies regarding the early detec-
tion or even prevention of osteoarthritis [146]. Additionally, it was
proven that AFM could be a valuable addition to the early detec-
tion of pathological changes that can be observed in tissue, as in
the case of physical trauma, burns, etc., or expressed in the struc-
tural deformations of certain biomolecules in the human body
[147,148]. The study and understanding of these changes is of utter
importance for our knowledge of the physiological mechanisms
leading to disease-related symptoms. This would not only allow
better symptom treatment, but would also form the basis for suc-
cessful prevention of the disease overall. Oberhauser et al. used AFM
to study the interaction strengths between the different domains
of ﬁbronectin, which is a protein comprising up to 15 type III
domains [15,149]. Their research was focused on the assessment
of the possibility of detecting conformational changes with force
spectroscopy. Force pulling experiments showed that the range of
forces required to unfold the weakest and strongest domains ranges
between 80 and 200 pN. Moreover, they studied the interconnec-
tion between the domains from which the protein is built. It was
found that several regions affect the behaviour of the others, indi-
cating a far more complex nature of such proteins, comprising a large
number of domains [149]. AFM proved to be suitable for the study
of these ﬁnemechanical changes appearing in the quaternary protein
structure. Such single molecule studies could hold the key to early
detection of conformational changes leading to neurodegenerative
diseases, such as Parkinson’s or Alzheimer’s disease [150–152].
Due to its versatile functions in the body and the relative com-
plexity of its structure, ﬁbronectin is an interesting protein for
research [153–155]. Although its main functions are connected
mostly with cell adhesion, growth, migration, and differentiation,
errors in its expression can lead to severe complications and even
cancer [156,157]. Hill et al. reviewed the use of AFM for imaging
of the cell surface and the simultaneous measurement of ligand-
receptor interactions on the cell surface, in order to assess ﬁbronectin
behaviour [158].
It was found that AFM not only enables the detection of cell mor-
phology and stiffness, but additionally allows the application of
discrete forces to single smooth muscle cells and the observation
of subsequent responses, which can serve as a basis for study of
complex mechanisms involved in the arteriolar myogenic re-
sponse (Fig. 9) [158]. The introduction of controlled and localised
forces with AFM seems to be a valuable tool for detecting disease-
related changes in the response of tissue. These changes, either in
Fig. 9. Example modes of AFM operation. (a) (i) A native, or non-functionalised, AFM probe enables the collection of detailed topographic information from viable cells. (ii)
A detail of the underlying cytoskeleton. (iii) A calculated topography map showing the relative height of the cell. Such images are usually achieved in the contact or tapping
mode operation of AFM, where the probe is controlled to scan across the cell surface with a preset contact force (ii). (b) (i) AFM probes functionalised were with ligand
molecules to enable the detection of individual ligand–receptor interactions on the cell surface. (ii) The probe is then lifted from the cell surface to break the ligand–
receptor bonds physically. (iii) The data obtained can be used to resolve the characteristic binding force of a speciﬁc ligand–receptor interaction. (c) (i) The tips of the AFM
probes can be replaced by microspheres. (ii) Bringing the ﬁbronectin–coated microspheres into contact with the vascular smooth muscle cell (VSMC) surface induces the
formation of focal-adhesion-like structures. The AFM probe can then be controlled to apply either pulling or pushing forces. (iii) As the contact time continues, increasing
force is required to detach FN-coated microspheres from the VSMC surface. (Figure reproduced from [158] with permission.).
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the protein structure or in the environmentally induced behavioural
changes of other species, can be used as an indication of an occur-
ring disease [159,160]. Various techniques have been used in recent
years to characterise the protein misfolding that facilitates the ag-
gregation process, leading to several diseases [161–163]. Additionally,
no real emphasis has been placed on the relation between the con-
formational transition and the increase in the intermolecular
interactions between the constituents of the misfolded proteins.
McAllister et al. applied AFM to follow the interaction between
protein molecules as a function of pH [164]. They performed in-
teraction mappings for three unrelated and structurally distinct
proteins, a-synuclein, amyloid b-peptide (Ab), and lysozyme. It was
shown that the attractive force between homologous protein mol-
ecules is minimal at physiological pH and increases dramatically at
acidic pH. Moreover, they found that the dependence of the pulling
forces is sharp, suggesting a pH-dependent conformational transi-
tion within the protein. In addition, protein self-assembly into
ﬁlamentous aggregates studied by AFM imaging was shown to be
facilitated at pH values corresponding to the maximum of pulling
forces [164]. This work is fundamental for studying the relation
between conformational changes in single protein structures in re-
lation to the disease that they cause. There are also other studies
relating pH to changes in the behaviour of macromolecules that in-
dicate the potential AFM can have in similar research [165–170].
Several methods for the detection of microbial pathogens are
commonly known and have been used for decades. Although dif-
ferent improvements have been introduced to these methods, novel
technological advancements led to another upsurge, some would
even say revolution, of methods for the early detection of patho-
gens [171,172]. Kaittanis et al. reviewed some of the possible
nanoarrays that use AFM-based methods as the sole method of de-
tecting microbial pathogens [173]. Another potential use of AFM in
the detection of pathogens is the use of speciﬁcally functionalised
AFM tips to detect possible infection even on samples of living tissue
[174].
2.3.2. Receptor-ligand interaction studies
Although the receptor-ligand binding kinetics have been thor-
oughly studiedwith differentmathematical models, the experimental
work is increasingly often performed using different variations of
force spectroscopy measurements and combinations of the men-
tioned approaches [175–177]. Such efforts are a basis for
understanding the underlying phenomena of histopathological tissue
changes in disease, either for their early detection or for the de-
velopment of novel therapies. Selectins have often been studied by
AFM-based measurements in recent years [178–180]. They have at-
tracted much interest in the biomedical community due to their
involvement in inﬂammation and their role in the “rolling” action
attributed to leukocytes during the leukocyte adhesion cascade. The
latter is the subject of thorough research on nanodevices, increas-
ing the “rolling” of cancer cells away from the tumour [181–184].
Several research efforts elucidating the mechanisms of this rolling
type of interaction have been performed over the last decade
[185–187]. Although different strategies have been used to study
these interactions (single molecule characterisation [131], the ki-
netics of their interactions with leukocytes [188], and cell adhesion
forces [128]), all of them have in common the search for interaction-
based disease-related changes by AFM force measurements.
2.3.3. Single molecule measurements
Probably the most advanced study with AFM is the examina-
tion of single molecule behaviour in its natural environment
[189–192]. Huber and Sakmar reviewed recent advances in molec-
ular and structural studies of G protein-coupled receptors, which
are some of the most studied receptors in recent years due to their
involvement in many biological functions [176,193]. The mecha-
nisms of their activity with regard to different circumstances on the
molecular scale is still somewhat blurry, which is why AFM has often
been employed to study the conformational, structural, and posi-
tional changes of these seven-trans-membrane domain receptors.
There has been increased interest in the use of novel molecular tech-
niques to study the behaviour of these proteins in their biological
environments while exposed to different species from their signal-
ling machineries [193,194]. The latter shows how biochemical
research is becoming increasingly exact and quantitative [193]. By
decreasing the gap between molecular and systems biology, such
efforts suggest a way forward from the ﬂatlands tomulti-dimensional
quantitative data collection and an understanding of biological
systems [193]. Single molecule AFM measurements can mainly be
divided into studies of different interacting species (in either real
or model systems), and the identiﬁcation of novel molecules in their
biological environment without damaging their native structure [66].
Dupres et al. addressed crucial challenges in modern cell biology
that are mostly based on understanding how cell-surface mol-
ecules are organised and how these characteristics change due to
the alternating conditions in the environment [195–197].
Information regarding these two issues is central to our under-
standing of cell adhesion and pathogen interactions. The past years
have witnessed rapid progress in the use of AFM to map the dis-
tribution of single polysaccharides and proteins on live cells and to
measure their molecular interactions (Fig. 10) [194,195]. Both types
of measurement are attracting many researchers due to their im-
portance in gaining further insight into the behaviour and response
of biological molecules to environmental changes [196,197].
The astonishing power of AFM with regard to single molecule
measurements was recently shown by Frei et al. [198,199]. They used
AFM to measure Au-N rupture forces using AFM in force spectros-
copy mode together with conductance measurements in various
amines. It was found that bond rupture force depends on the mo-
lecular backbone, which is in accordance with density functional
theory-based adiabatic molecular junction elongation and rupture
calculations [198,199] (Fig. 11). Such an approach not only shows
that several additional measurements can be implemented in AFM
by using force spectroscopy mode measurement to simultane-
ously gain additional insight into material/molecule characteristics,
but it also indicates that novel research should search for answers
by combining ideas from different ﬁelds of research.
2.4. Interaction mapping
One of the well-appreciated contributions of AFM to science in
the last decade is its ability to probe the interaction forces between
different molecules, particles, or surfaces [200–203]. The limita-
tion of this approach is the possibility to simulate or replicate the
actual environment in which themeasured interactions play a crucial
role and therefore have a huge impact on the ﬁnal product or on
the desired information. Recently, high yield intracellular delivery
has been one of the main targets of novel research in relation to
targeted drug delivery. Therefore, many research groups have sought
novel and more sophisticated ways to deliver drugs intracellularly
[204]. Because this is a complex task, a great deal of interest has
been focused on the study of interactions of the cell wall with dif-
ferent existing and newly developed particles or other delivery
systems [204]. AFM is able to evaluate cell morphology and stiff-
ness [205–207]. Additionally, it enables discrete forces to be applied
to single cells and their constituents, while the responses are ob-
served [158,208]. It can be concluded that AFM has become a
ubiquitous tool to image nanoscale structures and to estimate certain
mechanical characteristics of biological entities, ranging from DNA
to tissues [126,209–211]. Van Vliet and Hinterdorfer reviewed recent
advances in in situ investigations of drug-induced changes in cell
structure, membrane stability, and receptor interaction forces [212].
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They reviewed the ﬁrst attempts at AFM use in the progressive
optimisation of delivery systems by testing them together with their
targeted physiological structures (Fig. 12). They suggest that al-
though further efforts are needed to grasp all of the possibilities AFM
introduces to research, a large portion of the initial problems have
already been eliminated, thus allowing for world-changing re-
search [212].
Quantitative interaction mappings between species interacting
in real systems form the basis for an understanding of their ap-
pearance [200,213,214]. Allison et al. have demonstrated that AFM
Fig. 10. AFM in single molecule measurements. Mapping ﬁbronectin attachment proteins (FAPs) on Mycobacterium bovis bacillus Calmette-Guérin (BCG). (a) A schematic
representation of the experimental set-up, showing a ﬁbronectin-modiﬁed AFM tip and the mycobacterial cell wall. (b) Low- (inset; 2 μm × 2 μm) and high-resolution de-
ﬂection images of a living M. bovis BCG cell. (c) Adhesion force map (gray scale: 200 pN), and (d) adhesion force histogram with representative force curves, recorded on
the cell surface using a ﬁbronectin-tip. (Figure reproduced from [195] with permission.).
Fig. 11. AFM in measuring rupture forces of the Au-N bond. (A) Calculated total energy curves from adiabatic trajectories for 1,4-benzenediamine (red), 1,4-butanediamine
(blue), and 4,4′-bipyridine (green) shown as a function of displacement. The bars shown at right indicate the asymptotic values. (B) Calculated applied force curves for the
same molecules shown against displacement display the same trend as the experimental results. (C) Junction structure showing a 1,4–benzenediamine junction at 0.1 nm
elongation relative to the local energy minimum. (D) Zoom in of the Au—N bond indicating bond angle with respect to pulling direction. (E) Sample structure used to in-
vestigate a single Au—N bond force proﬁle for 1,4-benzenediamine bound to a gold electrode with the bond aligned to the pulling direction. (Figure reprinted with permission
from [199]. Copyright (2015) American Chemical Society.).
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can be used to measure forces between adenine-coated tips and
thymine-coated surfaces in order to develop the methodology to
study the required forces for unfolding immunoglobulin [215]. In
addition, they scanned albumin surfaces using an AFM tip with at-
tached anti-human serum albumin via a polyethylene glycol linker.
With the mentioned experimental set-up, they proved the exis-
tence of recognition between the antihuman serum albumin and
serum albumin due to their interactions (Fig. 13). When lysosome
was bound on the antibody, the recognition disappeared again, which
was clearly shown by means of AFM [215]. Several other studies
base their interaction mappings upon using AFM tips with at-
tached species of interest on one side and the other counterpart of
the interacting pair on the other [216–218].
2.5. Combinations of AFM with other methods
In recent years, there has been a tendency to combine the in-
formation that can be gathered with an AFM set-up with other
known techniques, such as infrared spectroscopy (IR), nuclear mag-
netic resonance (NMR), thermal analysis (TGA), mass spectrometry
(MS) and others [219–223]. Such combinations allow the assess-
ment of additional information regarding locally conﬁned properties
of nanomaterials. Several research groups are making additions to
the basic commercially available AFMs due to research speciﬁc mea-
surements, requiring nonstandard components.
An interesting example is the use of AFM in determination of
surface free energy, an important parameter in the calculation of
interstitial phenomena. A great deal of effort has been put into the
experimental assessment of this parameter, which could be com-
bined with theoretical considerations [115,224]. AFM was
successfully used in combination with a contact angle–based tech-
nique for the determination of surface free energy by Traini et al.
[225–227].
Probably the most interesting recent evolution of AFM is the in-
troduction of very fast scanning techniques, which allowed a real
time visualisation of a walking myosin molecule and of mem-
brane proteinmotion [192,228,229], as well as visualising living cells
in nanoresolution [230–232].
3. Conclusions
The present review addresses the basic concepts of AFM mea-
surements and the recent progress of AFM use in relation to
biomedical applications. The technical aspects are summarised in
a compact form, while theoretical considerations, which are not nec-
essary for an understanding thereof, are omitted. The increasing
number of research papers using AFM as a crucial part in the study
of different phenomena indicates intensiﬁed scientiﬁc awareness
of its capabilities.
As shown, AFM enables a vast range of research options. Its ex-
emplary resolution and ability to measure forces in the pN range
make it a valuable tool for analysis in relation to biomedical
applications.
Fig. 12. Characterisation of drug and gene delivery vehicles and mechanisms en-
hances vehicle development. (a) contact-mode error signal image of lipoplex, a
liposome containing DNA (DNA image, inset). Confocal optical microscopy of cells
transfected with these lipoplexes for 1 h shows that the lipoplexes are constrained
near the cell membrane in the presence of endocytosis inhibitors (b), whereas cells
transfected in the presence of membrane fusion inhibitors do not show such
localisation (c). Scale bars in (b) and (c) =10 μm. Inset scale bar = 200 nm. (Figure
reproduced from [212] with permission.).
Fig. 13. A time course of events to illustrate force-recognition imaging. (a) An antibody to lysozyme tethered to the AFM tip is scanned in a liquid environment over a surface
of immobilised lysozyme molecules. In this experiment, a low concentration of lysozyme is added to the liquid system. In I, the antibody on the tip has not bound free
lysozyme and is reacting with surface-bound lysozyme molecules. This is clearly seen in (b) and part of (c), where recognition imaging is evident by the distortion of the
images. In II, at the black arrow, the antibody on the tip has bound solution lysozyme and the image in part of (c) and all of (d) switches from recognition to topographic
imaging. (Figure reproduced from [215] with permission.).
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The amount of newly published work with AFM regarding novel
drug discoveries, their delivery, or their relation to the tissue they
try to mend is astonishing and heralds a bright future for AFM-
based research in this area.
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